Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron T Gerds

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
JAMA Oncology|September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of MortalityMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With MomelotinibClaire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Bone Marrow Transplantation|July 27, 2022
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromesSanghee Hong, Lisa Rybicki, Carmelo Gurnari, et al.
Haematologica|August 16, 2019
Genomics of therapy-related myeloid neoplasmsTeodora Kuzmanovic, Bhumika J Patel, Srinivasa R Sanikommu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2025
Comparing Outcomes of First-Line Intensive Chemotherapeutic Regimens in Adult Patients With Acute Lymphoblastic Leukemia at a Tertiary CenterAhmed Mohamed, Emily C Zabor, Meera Patel, et al.
Hemasphere|November 1, 2023
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 TrialsJean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
JAMA Oncology|September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of MortalityMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With MomelotinibClaire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Bone Marrow Transplantation|July 27, 2022
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromesSanghee Hong, Lisa Rybicki, Carmelo Gurnari, et al.
Haematologica|August 16, 2019
Genomics of therapy-related myeloid neoplasmsTeodora Kuzmanovic, Bhumika J Patel, Srinivasa R Sanikommu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2025
Comparing Outcomes of First-Line Intensive Chemotherapeutic Regimens in Adult Patients With Acute Lymphoblastic Leukemia at a Tertiary CenterAhmed Mohamed, Emily C Zabor, Meera Patel, et al.
Hemasphere|November 1, 2023
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 TrialsJean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
Pageof 14